Pathomechanisms in rheumatoid arthritis - Time for a string theory?

Journal of Clinical Investigation

Volumn 116, Issue 4, 2006, Pages 869-871

  Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; HUMAN; INFLAMMATION; MATHEMATICS; NONHUMAN; PATHOGENESIS; PHYSICS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOIMMUNITY; CITRULLINE; HUMANS; MICE; MODELS, THEORETICAL;

EID: 33645511450     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI28300     Document Type: Review

References (18)

1. Zwiebach, B. 2004. A first course in string theory. Cambridge University Press. Cambridge, Massachusetts, USA. 578 pp.
2. Kunkel, H.G., and Williams, R.C. 1964. Rheumatoid arthritis. Annu. Rev. Med. 15:37-52.
3. Nienhuis, R.L., and Mandema, E. 1964. A new serum factor in patients with rheumatoid arthritis; the antiperinuclear factor. Ann. Rheum. Dis. 23:302-305.
4. Simon, M., et al. 1993. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis. J. Clin. Invest. 92:1387-1393.
5. Schellekens, G.A., et al. 2000. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43:155-163.
6. Kuhn, K.A., et al. 2006. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J. Clin. Invest. 116:961-973. doi:10.1172/JCI25422.
7. Goronzy, J.J., and Weyand, C.M. 2005. Rheumatoid arthritis. Immunol. Rev. 204:55-73.
8. Paleolog, E.M. 2002. Angiogenesis in rheumatoid arthritis. Arthritis Res. 4:S81-S90.
9. Takemura, S., et al. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167:1072-1080.
10. Kang, Y.M., et al. 2002. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 195:1325-1336.
11. Seyler, T.M., et al. 2005. BLyS and APRIL in rheumatoid arthritis. J. Clin. Invest. 115:3083-3092. doi:10.1172/JCI25265.
12. Goronzy, J.J., and Weyand, C.M. 2004. T-cell regulation in rheumatoid arthritis. Curr. Opin. Rheumatol. 16:212-217.
13. Chen, Q., and Wei, W. 2005. New therapeutic approaches for rheumatoid arthritis. Assay Drug Dev. Technol. 3:329-337.
14. Edwards, J.C., et al. 2004. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350:2572-2581.
15. Kremer, J.M., et al. 2005. Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 52:2263-2271.
16. Gell-Mann, M. 1994. The quark and the jaguar: adventures in the simple and the complex. W.H. Freeman and Sons. New York, New York, USA. 392 pp.
17. Witten, E. 2005. Unravelling string theory. Nature. 438:1085.
18. Gell-Mann, M. 2001. Consciousness, reduction, and emergence. Some remarks. Ann. N. Y. Acad. Sci. 929:41-49.